[1]
A. Aleem, “Low Rate of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Despite Limited Use of Intrathecal Prophylaxis”, J Hematol, vol. 14, no. 1, pp. 14–19, Feb. 2025, doi: 10.14740/jh1363.